Healwell AI Achieves Financial Milestone with First Profitable Year

Healwell AI reports a 427% revenue surge to $103.8M and positive adjusted EBITDA of $2.3M, marking a strategic pivot to a pure-play AI software company.

Healwell AI Inc. has released its fiscal 2025 results, marking a definitive strategic pivot for the company. For the first time in its history, the firm reported a full year of positive adjusted EBITDA, a key profitability metric. This achievement underscores a fundamental shift in its business trajectory.

A Surge in Revenue and a Path to Profitability

Revenue from continuing operations soared to approximately $103.8 million for the year. This figure represents a staggering 427% increase from the $19.7 million recorded in the prior fiscal period. The company's adjusted EBITDA landed at $2.3 million, a dramatic turnaround from a loss of $14.2 million a year earlier. Management attributes this significant improvement to the expansion of its artificial intelligence platform and the integration of higher-margin software services.

While a net loss of $39.1 million was reported under IFRS accounting standards, a closer look reveals positive momentum. The net loss per share narrowed substantially to $0.02 in the fourth quarter, indicating a strengthening operational foundation.

Strategic Refocus and Portfolio Optimization

A major component of Healwell's new direction involved divesting lower-margin segments. In Q4 2025, the company exited several clinical and patient-facing service businesses, generating proceeds of about $9.7 million. This move is part of a deliberate strategy to transform Healwell into a pure-play AI and software entity, which is expected to deliver structurally superior margins over the long term.

Growth Initiatives and Financial Position

The company is not just restructuring but also expanding its reach. Growth milestones for the period include securing an inaugural contract with a government healthcare system in the Middle East. Furthermore, Healwell landed a multi-million dollar software agreement with a U.S.-based Health Information Exchange aimed at enhancing data interoperability between hospitals.

Healwell's balance sheet remained solid, closing the year with $18.6 million in cash and equivalents. The company also holds strategic equity investments, including a stake in xAI, which is now part of the SpaceX ecosystem. Management is currently evaluating the potential divestment of these holdings to further bolster its financial resources.

The scientific underpinning of its core DARWEN AI platform continues to be validated, with 47 peer-reviewed publications released as of mid-March 2026.

Despite the operational progress, the market has yet to fully reward the turnaround. The company's shares currently trade approximately 55% below their 52-week high, which was reached in March 2025.